Thermo Fisher Scientific (NYSE: TMO) has announced a 10-year virtual power purchasing agreement (VPPA) with X-ELIO for the Lorca solar project, expected to be operational in early 2026. The company’s 73 MW portion will generate approximately 150,000 megawatt-hours of renewable electricity annually, equivalent to powering 40,500 European homes for a year.
This agreement, combined with the previously announced Serbal solar project, will enable TMO to match all its addressable European sites with 100% renewable electricity. The project advances the company’s goal of achieving 80% global renewable electricity by 2030. The agreement includes a cohort of pharmaceutical partners (GSK, Gilead Sciences, and Haleon) through the Energize initiative, helping reduce both Scope 2 and Scope 3 emissions.
TMO serves as the cohort lead for this agreement, which aligns with its commitment to reach…
